April 2022 newsletter
Sneak peek at Flare™ V6 for medicinal chemists This sneak peek gives insight to just a few of the new features ...
Metabolic stability of a compound is a key factor in drug discovery and development. Several compounds with promising pharmacological properties fail to become drugs due to poor metabolic stability profiles. In this case study, we demonstrate how bioisosteric replacements can be useful in addressing metabolic liabilities using our bioisostere replacement and scaffold hopping software, Spark.
Our Cresset Discovery team comprising of expert modelers and medicinal chemists can work together with you to bring a unique perspective, remove obstacles and advance your flavor and fragrance discovery projects efficiently and cost-effectively.
Cresset Discovery, provider of contract consulting for early phase discovery, has been appointed by Globachem, who specialize in developing and marketing high quality crop protection products, to upskill their in-house team and assist them in developing the next generation of novel agrochemicals.
This is a unique opportunity to gain experience in all departments of our software and contract research business units. Your career at Cresset will start with a comprehensive, tailored rotational program across both scientific and commercial disciplines to broaden your exposure and skillset.
Join us in a celebration of the life and work of Andy Vinter, founder of Cresset. The meeting will deliver scientific content built on the unique and insightful approach that Andy took to molecular modeling throughout his distinguished career from his early days at Wellcome to his pioneering work on the eXtended Electron Distribution (XED) force field, which was foundational in the creation of Cresset. We hope you’re able to join us, either in-person or virtually, not only in celebration of Andy’s work but also his great sense of humour and irrepressible and joyous irreverance!